Maverick Therapeutics  is a preclinical stage biotech company founded by MPM that is developing a novel class of T cell- redirecting antibody.   Critical to the opportunity, the antibodies are designed to expand the therapeutic index via their conditional activation in the tumor microenvironment.

mavericktx.com